Earendil Labs is a biotechnology company developing technology platforms that transform therapeutic protein discovery.
Earendil Labs has raised $787.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2026.
Earendil Labs's investors include Sanofi, INCE Capital, Luminous Ventures (former Lightspeed China Partners), Dimension Capital, DST Global.
Earendil Labs is headquartered in Middletown, United States.
Earendil Labs is a biotechnology company developing technology platforms that transform therapeutic protein discovery.
Earendil Labs is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Earendil Labs — Funding & Investors." VCBacked, March 20, 2026, https://www.vcbacked.co/company/earendil-labs. Accessed September 30, 2026.
VCBacked. (2026). Earendil Labs — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/earendil-labs
{{cite web |title=Earendil Labs — Funding & Investors |url=https://www.vcbacked.co/company/earendil-labs |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated